Common drugs of abuse.

Drug Detection and Monitoring Chart

Alere Toxicology helps you make informed decisions. The use of this chart will help you identify, understand, and monitor commonly abused
substances. Turn to Alere to perform compliant, accurate, and reliable drug screens customized for your detection and monitoring needs.

AVERAGE AVERAGE
DRUG CLASS AND DEA DRUG/METABOLITE
COMMON DRUG NAMES STREET NAMES WAYS USED ADDICTION AND WITHDRAWAL DETECTION DETECTION
DRUG ANALYTES SCHEDULE1 MONITORED
TIME URINE TIME ORAL FLUID

O P IAT E S / OPIOID S
Oral; intrarectal; intramuscular; Moderate-to-low risk of physical or psychological dependence. Withdrawal symptoms may include
Codeine Tylenol® #3 Schoolboy Schedule II Codeine, morphine 1-3 days 1-2 days
subcutaneous drug craving, runny nose, yawning, sweating, insomnia, weakness, stomach cramps, etc.
Lorcet®, Lortab®, Hycodan®, Norco®, Moderate potential of physical or psychological dependence. Withdrawal symptoms may include Hydrocodone, hydromorphone,
Hydrocodone Hydros, dones, vics, itchies Schedule II Oral 1-3 days 1-2 days
Vicodin®, Vicoprofen® severe pain, pins and needles, sweating, extreme anxiety, restlessness, sneezing, etc. norhydrocodone
Oral; intramuscular; intravenous;
Moderate-to-high risk of physical or psychological dependence. Withdrawal symptoms may include
Hydromorphone Dilaudid®, Hymorphan® Juice, dillies, M2s, hospital heroin Schedule II subcutaneous; intranasal; rectal; sublin- Hydromorphone 1-3 days 1-2 days
shaking, cold sweats, diarrhea, vomiting, self-doubt, emptiness, etc.
gual; transmucosal; buccal; transdermal
Smoking; snorting; oral; rectal;
Avinza®, Kadian®, MS Contin®, MSIR®, High potential for physical or psychological dependence. Withdrawal symptoms may include
Morphine M, morph Schedule II subcutaneous; intramuscular; Morphine 1-3 days 1-2 days
Roxanol®, Embeda® several stages ranging from drug craving and anxiety to vomiting or loss of appetite.
intravenous; intrathecal
Oral; intramuscular; intravenous;
Tylox®, Percocet®, Percodan®, Moderate-to-high risk of physical or psychological dependence. Withdrawal symptoms may Oxycodone, oxymorphone,
Oxycodone Oxy-cofins, killers, percs Schedule II intranasal; subcutaneous; transdermal; 1-3 days 1-2 days
OxyContin®, OxyIR®, Roxicodone® include anxiety, panic attacks, nausea, muscle pain, fevers, etc. noroxycodone
rectal; epidural
Intravenous; intramuscular; subcutane- High risk of physical or psychological dependence. Withdrawal symptoms may include anxiety,
Oxymorphone Opana ER®, Opana IR®, Numorphan® Blues, nu-blues, biscuits, blue heaven Schedule II Oxymorphone 1-3 days 1-2 days
ous; oral; rectal; intranasal panic attacks, nausea, muscle pain, fevers, etc.

S Y NT H E TI C OPIOID S
Suboxone®, Subutex®, Sublingual; intramuscular; intravenous; Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Buprenorphine N/A Schedule III Buprenorphine, norbuprenorphine 3-5+ days 1-2+ days
Buprenex®, Butrans® transdermal; intranasal; rectal are typically less severe than other opioids.

Actiq®, Fentora®, Onsolis®, Transdermal; intramuscular; intravenous; Moderate-to-high risk of physical or psychological dependence. Risk of postacute-withdrawal
Fentanyl N/A Schedule II Fentanyl, norfentanyl 1-4 days 1-3 days
Duragesic®, Sublimaze® oral; sublingual; buccal syndrome leading to possible psychiatric disorders, depression, anxiety, etc.

Due to rapid onset, meperidine is more likely to be abused than other prescription opioids.
Meperidine Demerol® Demmies, pain killer Schedule II Oral; intranasal; rectal; intravenous Meperidine, normeperidine 1-3 days 1-2 days
Like other opioids, there is a potential for physical dependence.
Oral; intravenous; insuflation; According to some physicians, methadone causes less of a euphoric high. Often used as Methadone, EDDP (2-ethylidene-1,5-
Methadone Methodose®, Dolophine® Dollies, meth Schedule II 1-7 days 1-2 days
sublingual; rectal an intermediate drug in opioid addiction recovery programs. dimethyl-3,3-diphenylpyrrolidine
Pentazocine Talwin® T’s Schedule IV Oral; intravenous; intramuscular Moderate-to-low physical dependence risk. May have risk of psychological dependence. Pentazocine 1-3 days 1-2 days
Nonscheduled
by itself,
Propoxyphene Darvocet®, Darvon® Pain killer Oral; intravenous; rectal Risk of limited physical or psychological dependence with prolonged use. Norpropoxyphene, propoxyphene 1-7 days 1-2 days
Schedule IV in
combination.
High risk of physical or psychological dependence. Withdrawal symptoms may include anxiety,
Tapentadol Nucynta® N/A Schedule II Oral Tapentadol, desmethyltapentadol 1-3 days 1-2 days
sweating, trouble sleeping, etc.
Oral; intravenous; intramuscular; Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms
Tramadol Ryzolt®, Ultracet®, Ultram® N/A Schedule IV Tramadol, O-desmethyltramadol 1-3 days 1-2 days
rectal; sublingual; buccal; intranasal may include anxiety, depression, anguish, sweating, restless legs, etc.

S T I MU L AN TS
Aimies, back dex, bennies, black beauties, brain pills, bumblebees,
Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms
Amphetamine Adderall®, Benzedrine®, Dexedrine® cartwheels, dexies, marathons, minibennie, pep pills, pixies, road Schedule II Oral, typical dosage: 5-15 mg Amphetamine 2-4+ days 1-3 days
may include extreme hunger, fatigue, shaking, seizures, arrhythmia, etc.
dope, speed, truck drivers, uppers
Ritalin®, Concerta®, High risk of physical or psychological dependence. Withdrawal symptoms may include
Methylphenidate N/A Schedule II Oral; transdermal Methylphenidate, ritalinic acid 2-4 days 1-2 days
Methylin®, Provigil® depression, extreme fatigue, etc.
Smoking; insuflation; oral; transdermal; High potential for physical or psychological dependence. Withdrawal symptoms may include
Nicotine Nicorette®, Nicoderm® N/A Nonscheduled Cotinine, 3-OH-cotinine 2-4 days 2-4 days
intrabuccal; vaporized; buccal anxiety, irritability, headache, hunger, craving for cigarettes, etc.

B EN Z O DI A ZEPIN ES
Risk of limited physical or psychological dependence with prolonged use. Withdrawal Alprazolam, α-hydroxy
Alprazolam Xanax®, Niravam®, Xanor® Downs, nerve pills, tranks Schedule IV Oral 2-8 days 1-2 days
symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. alprazolam
Angirex®, Elenium®, Klopoxid®,
Librax®, Libritabs®, Librium®, Mesural®, Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Chlordiazepoxide Downs, nerve pills, tranks Schedule IV Oral; intramuscular Nordiazepam, oxazepam 1-7 days 1-2 days
Multum®, Novapam®, Risolid®, symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Silibrin®, Sonimen®, Tropium®
Oral; intravenous; Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Clonazepam Klonopin® Downs, nerve pills, tranks Schedule IV Clonazepam, 7-amino clonazepam 3-14 days 1-2 days
intramuscular; sublingual symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Clorazepate Tranxene®, Novo-Clopate® Downs, nerve pills, tranks Schedule IV Oral Nordiazepam, oxazepam 1-7 days 1-2 days
symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Oral; intramuscular; Risk of limited physical or psychological dependence with prolonged use. Withdrawal Diazepam, temazepam,
Diazepam Valium® Downs, nerve pills, tranks Schedule IV 3-14 days 1-2 days
intravenous; suppository symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. nordiazepam, oxazepam
Risk of limited physical or psychological dependence with prolonged use. Withdrawal N1-desalkyl-lurazepam,
Flurazepam Dalmane®, Dalmadorm® Downs, nerve pills, tranks Schedule IV Oral 1-3 days 1-2 days
symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. hydroxyethyl-lurazepam
Oral; intramuscular; intravenous; Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Lorazepam Ativan® Lorax®, Emotavil® Downs, nerve pills, tranks Schedule IV Lorazepam 2-5 days 1-2 days
sublingual; transdermal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Oral; intramuscular; Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Midazolam Versed, Dormicum, Hypnovel® Downs, nerve pills, tranks Schedule IV
intravenous; parenteral symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
α-Hydroxymidazolam 1-3 days 1-2 days

1-3 days
Murelax®, Serax®, Serepax®, Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Oxazepam Downs, nerve pills, tranks Schedule IV Oral Oxazepam 4-6 weeks 1-2 days
Alepam®, Adumbran® symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Chronic use 2
King Kong pills, jellies, jelly, Edinburgh eccies, tams, terms, mazzies,
temazies, tammies, temmies, beans, eggs, green eggs, wobbly eggs,
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Temazepam Restoril®, Tenox®, Euhypnos® knockouts, hardball, norries, oranges, rugby balls, ruggers, terminators, Schedule IV Oral Temazepam, oxazepam 1-4 days 1-2 days
symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
red and blue, no-gos, blackout, green devils, drunk pills, brainwash,
mind erasers, tem-tems, mommy's big helper, vitamin T, bit T, TZ

M U S C LE REL AXAN T S
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Carisoprodol Soma®, Soprodal® Dance, DS, Las Vegas cocktail, soma coma, wallace 200s Schedule IV Oral Carisoprodol, meprobamate 2-5 days 1-2 days
symptoms may include stomach pain, sleep problems, headache, nausea, seizure, etc.
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Meprobamate Miltown®, Equanil®, Meprospan® Dance, DS, Las Vegas cocktail, soma coma, wallace 200s Schedule IV Oral Meprobamate 2-5 days 2-3 days
symptoms may include vomiting, ataxia, tremors, muscle twitching, confusion, etc.

B AR B I T U R AT ES
Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Amobarbital Amytal® Yellow jackets, angels, downers, red birds, phennies, yellows, tootsies Schedule II Oral; intravenous; intramuscular; rectal Amobarbital 3-10 days 1-2 days
may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Butabarbital Butisol®, Butibel® Yellow jackets, angels, downers, red birds, phennies, yellows, tootsies Schedule III Oral Butabarbital 1 day–3 weeks 1-2 days
may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
Yellow jackets, angels, downers, red birds, phennies, yellows, Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Butalbital Fiorinal®, Fioricet® Schedule III Oral Butalbital 3-10 days 1-2 days
tootsies, schoolboys may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Pentobarbital Nembutal® Yellow jackets, angels, downers, red birds, phennies, yellows, tootsies Schedule II Oral; intravenous; intramuscular; rectal Pentobarbital 3-10 days 1-2 days
may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
Yellow jackets, angels, downers, red birds, phennies, yellows, Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms
Phenobarbital Belladonna®, Luminal® Schedule IV Oral; rectal; intravenous; intramuscular Phenobarbital 1 day–4 weeks 1-2 days
tootsies, goofballs may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
Schedule II
® Yellow jackets, angels, downers, red birds, phennies, yellows, by itself, Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms
Secobarbital Seconal Oral Secobarbital 3-10 days 1-2 days
tootsies, barbs, reds Schedule III may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc.
in combination.

TR I CY CLI C AN T ID EPRES SAN T S (TCA)

Little to no risk of physical or psychological dependence; however, there are withdrawal
Amitriptyline Elavil®, Endep® N/A Nonscheduled Oral Amitriptyline, nortriptyline 2-14 days 1-2 days
side effects such as nausea, headache, insomnia, or anxiety.
Little to no risk of physical or psychological dependence; however, there are withdrawal
Desipramine Norpramin® N/A Nonscheduled Oral Desipramine 3-15 days 1-2 days
symptoms such as headache, nausea, and malaise.
Little to no risk of physical or psychological dependence; however, there are withdrawal
Doxepin Sinaquan®, Adapin® N/A Nonscheduled Oral; intramuscular; intravenous Doxepin, desmethyldoxepin 2-8 days 1-2 days
symptoms such as agitation, anxiety, insomnia, and, sometimes, rebound depression.
Tofranil®, Tofranil-PM Little to no risk of physical or psychological dependence; however, there are withdrawal side
Imipramine N/A Nonscheduled Oral Imipramine, desipramine 1-6 days 1-2 days
(desipramine metabolite) effects such as headache, restlessness, diarrhea, nausea, and lu-like symptoms.
Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms
Maprotiline Ludiomil®, Deprilept®, Psymion® N/A Nonscheduled Oral; intramuscular; intravenous Maprotiline 7-10 days 1-2 days
such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression.
Pamelor®, Aventyl® Little to no risk of physical or psychological dependence; however, there are withdrawal
Nortriptyline N/A Nonscheduled Oral Nortriptyline, hydroxynortriptyline 4-21+ days 1-2 days
(amitriptyline metabolite) symptoms such as headache and nausea.

N EU R O PATH IC S
Abuse may lead to limited physical dependence or psychological dependence. Withdrawal
Gabapentin Neurontin® N/A Nonscheduled Oral Gabapentin 1-3 days 1-2 days2
symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc.
Abuse may lead to limited physical dependence or psychological dependence. Withdrawal
Pregabalin Lyrica® Lycia Schedule V Oral; intravenous; insuflation Pregabalin 1-3 days 1-2 days2
symptoms may include restlessness, insomnia, anxiety, relapse of seizures, etc.

S E LE C T I VE S EROT ONIN REU PTAKE INHI BITO RS (S SRI )

Low risk of physical or psychological dependence. Withdrawal symptoms may include lu,
Fluoxetine Prozac®, Sarafem®, Fontex® N/A Nonscheduled Oral Fluoxetine, norluoxetine No data No data
headache, chills, fatigue, nausea, hallucinations, suicidal thoughts, etc.
Low risk of physical or psychological dependence. Withdrawal symptoms may include
Sertraline Zoloft®, Lustral® N/A Nonscheduled Oral Sertraline, norsertraline No data No data
dizziness, electric shock–like sensations, sweating, nausea, tremor, insomnia, etc.

S E D ATI V E S /H Y PN OT IC S

Risk of limited physical or psychological dependence with prolonged use. Withdrawal

Methaqualone Quaalude Ludes Schedule I Oral Methaqualone 2-4 days No data
symptoms may include restlessness, irritability, antisocial behavior, insomnia, headache, etc.

Risk of limited physical or psychological dependence with prolonged use. Withdrawal

Zaleplon Sonata®, Starnoc® N/A Schedule IV Oral; intranasal Zaleplon No data No data
symptoms may include depression, anxiety, stomach/muscle cramps, vomiting, etc.
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Zolpidem Ambien®, Stilnox®, Sublinox® A-minus, zombie pills, no-go pills Schedule IV Oral; sublingual; oromucosal Zolpidem, carboxyzolpidem 1-2 days 1-2 days
symptoms may include delirium, seizure, anxiety, irritability, insomnia, etc.
Risk of limited physical or psychological dependence with prolonged use. Withdrawal
Zopiclone Imovane® Zimmers, zimmies, zim-zims, zoppies Schedule IV Oral Zopiclone 1-2.5 days No data
symptoms may include anxiety, tachycardia, tremor, sweats, lushes, insomnia, etc.

I LLI CI T S/ NON PRES C RIPT ION DRUGS

Alcohol: 1-2 days
Low-to-high risk of physical or psychological dependence. Symptoms include tolerance, Blood alcohol
Ethanol,
withdrawal, perpetually increasing consumption, persistent desire, lost time drinking or decreases
Alcohol N/A Booze, wine, beer, and ethanol Nonscheduled Oral; intramuscular; intravenous; topical ethyl glucuronide (EtG), 6-24 hours
recovering, abandonment of social activities for alcohol, and continued use despite knowledge .02 mg% per hour
ethyl sulfate (EtS)
of physical or psychological damage. EtG/EtS: up to
80 hours
MDPV, pyrovalerone, 3-luorometh-
cathinone, butylone, ethylone, MDAI,
High potential for abuse and physical or psychological dependence. Withdrawal symptoms methylone, naphyrone, buphedrone,
Cathinones3 “Bath salts,” or veiled as ecstasy Molly, Cloud 9, Ivory Wave, Flakka Schedule I Oral; intranasal; insuflation; intravenous 2-3 days2 1-2 days
may include runny nose, nosebleeds, cravings for sweets, muscle spasm, etc. mephedrone, methedrone, eutylone,
PVP (list updated periodically and
varies by laboratory)
Aunt nora, barbs, blow, coke, dream, foo-foo dust, her, king’s habit, High risk of physical or psychological dependence. Withdrawal symptoms may include
Cocaine N/A Schedule II Topical; oral; insuflation; intravenous Benzoylecgonine 1-7 days 1-2 days
Peruvian lady, snow, stardust, witch, zip unpleasant dreams, insomnia, or hypersomnia.
Low potential for physical or psychological dependence. Withdrawal symptoms may
Dextromethorphan N/A Dex, DXM, robo, skittles, syrup, triple-c, vitamin D, tussin Nonscheduled Oral Dextromethorphan 24 hours2 No data
include insomnia, anxiety, restlessness, vomiting, severe weight loss, diarrhea, etc.
Dragon, dope, hera, H, big H, white, China white, white nurse, white
lady, white horse, boy, black tar, black pearl, black stuff, black eagle,
Inhalation; transmucosal; intravenous; High potential for physical or psychological dependence. Withdrawal symptoms include 6-MAM- 6-8 hours
Heroin N/A brown crystal, brown sugar, brown tape, brown rhine, Mexican brown, Schedule I 6-MAM, morphine, codeine 8 hours
oral; intranasal; rectal; intramuscular sweating, malaise, anxiety, depression, insomnia, cold sweats, etc. 1-3 days
Mexican mud, Mexican horse, junk, tar, snowball, snow, white boy,
smack, scag, scat, sack, skunk, number 3, 4, 8
K, ket, special K, vitamin K, vit K, kit kat, keller, kelly’s day, green, blind Oral; intravenous; intramuscular; Moderate risk of physical or psychological dependence. Withdrawal symptoms may include
Ketamine Ketanest®, Ketaset®, Ketalar® Schedule III Ketamine, norketamine 2-4 days No data
squid, cat valium, purple, special la coke, super acid, super C insuflation; topical chills, intense cravings, restlessness, nightmares, anxiety, tremors, sweating, etc.
Abuse risk debated. Frequent use is known to cause nervousness, skin darkening, constipation,
Kratom Mitragyna speciosa Krathom, biak-biak, cratom, mitragyne, gratom Schedule I Smoking; chewing 7-Hydroxymitragynine No data No data
nausea, etc. Can sometimes cause cross-tolerance for morphine.
N-Desmethyl-LSD, hydroxy-
High potential of abuse despite low addiction potential. Discontinuation symptoms may include
Lysergic acid diethylamide N/A LSD, acid Schedule I Oral; intravenous; ocular; intramuscular LSD, 2-oxo-LSD, and 2-oxo- 1.5-5 days 1-2 days2
hallucinations, depression, anxiety, schizophrenia, confusion, etc.
3-hydroxy-LSD
Weed, pot, reefer, grass, dope, ganja, mary jane, hash, herb, aunt mary, Single use: 3 days;
11-OH-THC, 11-nor-9-carboxy-THC
skunk, boom, chronic, cheeba, blunt, ashes, baby bhang, bammy, moderate use: 5-7
High risk of physical or psychological dependence. Withdrawal symptoms may include (plus more than 100 possible
Marijuana (THC)3 Marinol®, marijuana, pot, reefer blanket, bomber, boom, broccoli, cripple, dagga, dinkie dow, ding, Schedule I Smoking; oral days; daily use: 24+ hours
irritability, sleeplessness, decreased appetite, anxiety, drug craving, etc. others, metabolite detection
dona juana, lower, lower tops, gasper, giggle smoke, good giggles, 10-15 days; long
may vary by laboratory)
good butt, hot stick, jay, jolly green, joy smoke, joy stick, roach term: >30 days
X, E, XTC, adam, beans, candy, dancing shoes, disco biscuits, doves,
Methylenedioxymethamphet- High potential for abuse despite low physical addiction potential. Addiction potential is
Ecstasy e-bombs, egg rolls, happy pill, hug drug, love drug, macolm, scooby Schedule I Oral, typical dosage: 50-150 mg MDMA, MDA 1-3 days 1-2 days2
amine (MDMA) debatable. Withdrawal symptoms may include fatigue, loss of appetite, depression, etc.
snacks, smartees, sweets, skittles, thizz, vitamin E, vitamin X, vowels
Crystal meth, crystal, meth, christina, tina, cris, cristy, ice, crank, High potential for abuse and physical or psychological dependence. Withdrawal symptoms may
Methadrine, Desoxyn®, Oral, typical dosage: 5-15 mg,
Methamphetamine speed, geep, geeter, getgo, go fast, poor man's coke, redneck Schedule II include irritability, depression, fearfulness, loss of energy, nausea, tremors, sweating, palpitations, Methamphetamine, amphetamine 1-4+ days 1-3 days
Desfedrin®, Ampedroxyn® intravenous, typical dosage: 20-40 mg
cocaine, working man's cocaine, trash, garbage, wash increased appetite, etc.
Methylenedioxyamphetamine
N/A MDA, love drug Schedule I Oral; sublingual High potential for abuse despite low physical addiction potential. MDA 1-3 days 1-2 days2
(MDA)
High risk of abuse and physical dependence. Withdrawal symptoms may include depression,
Phencyclidine (PCP) PCP Hog, angel dust, loveboat, lovely Schedule II Smoking; insuflation; oral PCP 2-30 days 1-2 days
anxiety, hypersomnia, poor memory, confusion, violent behavior, hallucinations, delusions, etc.
meta-Chlorophenylpiperazine
BZP Schedule I,
High potential for abuse and physical or psychological dependence. Withdrawal symptoms (mCPP), 3-triluoromethylphenyl-
Piperazines “Bath salts,” or veiled as ecstasy N/A all others are Oral; intranasal; insuflation; intravenous 2-3 days2 1-2 days
may include runny nose, nosebleeds, cravings for sweets, muscle spasm, etc. piperazine (TFMPP), and benzylpi-
drugs of concern.
perazine (BZP)
AKB-48, AM-1248, AM-2201, AM-
694, JWH-018, JWH-019, JWH-073,
JWH-081, JWH-122, JWH-200,
Synthetic High risk of abuse. Withdrawal symptoms may include internal unrest, tremor, palpitations, 1-3 days
“K2,” “Spice,” cannabimimetics K2, spice, synthetic marijuana, fake pot Schedule I Smoking, infusion JWH-203, JWH-210, JWH-250, 12-48 hours
cannabinoids3 headache, nausea, vomiting, depression, etc. (single dose only)
JWH-398, MAM-2201, RCS-4, RCS-
8, UR-144, XLR-11 (list updated
periodically and varies by laboratory)
The analytical methods used by Alere are scientiically accepted and approved by the U.S. Department of Health and Human Services. Comprehensive steroid and diuretic laboratory testing services also available. Contact your representative for more information. © 2017 Alere. All rights reserved. The Alere Logo, Alere, and Knowing now matters are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. MKT50328 REV1 4/17
1. Federal legal status listed may periodically change. 2. Detection window may vary. Times can be extended with higher dosages and increased frequency of use. 3. Alere laboratories may detect different metabolites or metabolites at different levels.

E-mail us: toxicology@alere.com | Visit us: aleretoxicology.com